The DOI matches its Crossref record.
High Sirolimus Levels May Induce Focal Segmental Glomerulosclerosis De Novo
Abstract
Sirolimus has been associated with high-range proteinuria when used in replacement of calcineurin inhibitors in renal transplant recipients with chronic allograft nephropathy (CAN). Primary FSGS was demonstrated previously in some such patients, but the coexistence of CAN lesions made the interpretation uneasy. However, nephrotic syndrome and FSGS were observed recently in three patients who received sirolimus de novo, without medical history of primary FSGS or CAN. Markers of podocyte differentiation were studied in kidney biopsies of the three patients who received sirolimus de novo and of five patients who switched to sirolimus. All patients developed FSGS lesions of classic type (not otherwise specified), but only switched patients exhibited advanced sclerotic lesions. Immunohistochemistry showed that some podocytes in FSGS lesions had absent or diminished expression of the podocyte-specific epitopes synaptopodin and p57, reflecting dedifferentiation, and had acquired expression of cytokeratin and PAX2, reflecting a immature fetal phenotype. Such a pattern of epitope expression provides evidence for podocyte dysregulation. Moreover, a decrease in vascular endothelial growth factor expression was observed in some glomeruli. In conclusion, sirolimus induces FSGS that is responsible for proteinuria in some transplant patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kopp, J. B., Anders, H.-J., Susztak, K., Podestà, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0196-7 · Cited by 562
Focal Segmental Glomerulosclerosis
Rosenberg, A. Z., & Kopp, J. B. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05960616 · Cited by 562
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44774 · Cited by 547
Renal Vulnerability to Drug Toxicity
Perazella, M. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02050309 · Cited by 403
Management of Childhood Onset Nephrotic Syndrome
Gipson, D. S., Massengill, S. F., Yao, L., Nagaraj, S., Smoyer, W. E., Mahan, J. D., Wigfall, D., Miles, P., Powell, L., Lin, J.-J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-1559 · Cited by 314
Metadata
- Authors
- Letavernier, E., Bruneval, P., Mandet, C., Van Huyen, J.-P. D., Pe[Combining Acute Accent]raldi, M.-N. D., Helal, I., Noe[Combining Diaeresis]l, L.-H. A. A. G. A., & Legendre, C.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2007-03
- Volume
- 2
- Issue
- 2
- Pages
- 326-333
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2111820685
- Cited by
- 200
- References
- 0
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High Sirolimus Levels May Induce Focal Segmental Glomerulosclerosis De Novo. https://app.cochat.ai/papers/10.2215/cjn.03751106
- The paper
- Letavernier, E., Bruneval, P., Mandet, C., Van Huyen, J.-P. D., Pe[Combining Acute Accent]raldi, M.-N. D., Helal, I., Noe[Combining Diaeresis]l, L.-H. A. A. G. A., & Legendre, C. (2007). High Sirolimus Levels May Induce Focal Segmental Glomerulosclerosis De Novo. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.03751106
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.